Skip to main content
. 2014 Dec 9;97(2):279–283. doi: 10.1189/jlb.2AB0514-273RR

Figure 3. Pharmacologic Akt activation induces Glut1 in Tregs.

Figure 3.

(A) Freshly isolated Tconv and Tregs (as shown in Fig. 1A) were stimulated with the Akt agonist SC79 (red histograms), CD3/CD28 mAb-coated beads and 300 U/ml IL-2 (black histograms) or left unstimulated (gray histograms) for 15 min. Cells were then stained with phospho-Ser473 Akt mAb. Data are representative of 3 independent experiments. (B, upper) Freshly isolated Tconv and Tregs (as shown in Fig. 1A) were stimulated with CD3/CD28 mAb-coated beads, IL-2 (300 U/ml), and a vehicle control (black histograms) or left unstimulated (gray histograms) for 20 h. (Lower) Freshly isolated Tconv and Tregs were stimulated with CD3/CD28 mAb-coated beads, IL-2 (300 U/ml), and SC79 (0.5 μg/ml) or left unstimulated for 20 h. Cells were then stained with anti-Glut1 mAb. (C) Summary of 3 independent experiments as shown in B (*P < 0.01). The data were plotted as the mean ± sd.